Taysha Gene Therapies
TSHA
TSHA
39 hedge funds and large institutions have $9.05M invested in Taysha Gene Therapies in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
71% less call options, than puts
Call options by funds: $2K | Put options by funds: $7K
Holders
39
Holding in Top 10
–
Calls
$2K
Puts
$7K
Top Buyers
| 1 | +$95.9K | |
| 2 | +$91.1K | |
| 3 | +$53.3K | |
| 4 |
DAS
Dynamic Advisor Solutions
Phoenix,
Arizona
|
+$29.7K |
| 5 |
Morgan Stanley
New York
|
+$28.8K |
Top Sellers
| 1 | -$1.28M | |
| 2 | -$312K | |
| 3 | -$217K | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$79.8K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$79.8K |